To test whether reduction of NSMCE2 transcript levels by SE disruption can sensitize breast cancer cells to chemotherapy-induced apoptosis, we treated breast cancer cells with BET inhibitor JQ1 and the standard chemotherapeutical drugs doxorubicin and paclitaxel. The gene discussed is NSMCE2; the disease is breast cancer.